Publication:
Recommendations for risk categorization and prophylaxis of invasive fungal diseases in hematological malignancies: A critical review of evidence and expert opinion (TEO-4)

Simple item page
dc.contributor.authorBoğa, Can
dc.contributor.authorBolaman, Zahit
dc.contributor.authorÇağırgan, Seçkin
dc.contributor.authorKaradoğan, İhsan
dc.contributor.authorÖzcan, Mehmet Ali
dc.contributor.authorSaba, Rabin
dc.contributor.authorSönmez, Mehmet
dc.contributor.authorŞenol, Esin
dc.contributor.authorAkan, Hamdi
dc.contributor.authorAkova, Murat
dc.contributor.buuauthorÖzkalemkaş, Fahir
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentİç Hastalıkları Ana Bilim Dalı
dc.contributor.researcheridAAG-8495-2021
dc.contributor.scopusid6601912387
dc.date.accessioned2024-02-19T12:38:38Z
dc.date.available2024-02-19T12:38:38Z
dc.date.issued2015
dc.description.abstractThis is the last of a series of articles on invasive fungal infections prepared by opinion leaders in Turkey. The aim of these articles is to guide clinicians in managing invasive fungal diseases in hematological malignancies and stem cell transplantation based on the available best evidence in this field. The previous articles summarized the diagnosis and treatment of invasive fungal disease and this article aims to explain the risk categorization and guide the antifungal prophylaxis in invasive fungal disease.
dc.identifier.citationBoğa, C. vd. (2015). "Recommendations for risk categorization and prophylaxis of invasive fungal diseases in hematological malignancies: A critical review of evidence and expert opinion (TEO-4)". Turkish Journal of Hematology, 32(2), 100-117.
dc.identifier.endpage117
dc.identifier.issn1300-7777
dc.identifier.issue2
dc.identifier.pubmed26316478
dc.identifier.scopus2-s2.0-84930743919
dc.identifier.startpage100
dc.identifier.urihttps://doi.org/10.4274/tjh.2014.0277
dc.identifier.urihttps://jag.journalagent.com/tjh/pdfs/TJH_32_2_100_117.pdf
dc.identifier.urihttps://hdl.handle.net/11452/39853
dc.identifier.volume32
dc.identifier.wos000369116200001
dc.indexed.scopusScopus
dc.indexed.trdizinTrDizin
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherGalenos Yayınları
dc.relation.collaborationYurt içi
dc.relation.collaborationSanayi
dc.relation.journalTurkish Journal of Hematology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectHematology
dc.subjectHematological malignancy
dc.subjectInvasive fungal infections
dc.subjectProphylaxis
dc.subjectRisk
dc.subjectStem-cell transplantation
dc.subjectReceiving antifungal prophylaxis
dc.subjectBone-marrow-transplantation
dc.subjectPlacebo-controlled trial
dc.subjectDouble-blind trial
dc.subjectCancer-patients
dc.subjectMold infections
dc.subjectSingle-center
dc.subjectPulmonary aspergillosis
dc.subjectFluconazole prophylaxis
dc.subject.emtreeAlemtuzumab
dc.subject.emtreeAmphotericin B deoxycholate
dc.subject.emtreeAmphotericin B lipid complex
dc.subject.emtreeAnidulafungin
dc.subject.emtreeAnthracycline
dc.subject.emtreeCaspofungin
dc.subject.emtreeCell surface protein
dc.subject.emtreeCorticosteroid
dc.subject.emtreeCytochrome P450 isoenzyme
dc.subject.emtreeDiphtheria toxoid CRM197
dc.subject.emtreeEchinocandin
dc.subject.emtreeFluconazole
dc.subject.emtreeFructose bisphosphate aldolase
dc.subject.emtreeGlucan glucosidase
dc.subject.emtreeGlucuronoxylomannan
dc.subject.emtreeItraconazole
dc.subject.emtreeLaminaran
dc.subject.emtreeMalate dehydrogenase
dc.subject.emtreeMannan
dc.subject.emtreeMicafungin
dc.subject.emtreePlacebo
dc.subject.emtreePosaconazole
dc.subject.emtreeRapamycin
dc.subject.emtreeRecombinant protein
dc.subject.emtreeRituximab
dc.subject.emtreeSignaling lymphocyte activation molecule associated protein
dc.subject.emtreeTriazole
dc.subject.emtreeUnindexed drug
dc.subject.emtreeVincristine
dc.subject.emtreeVoriconazole
dc.subject.emtreeAntifungal agent
dc.subject.emtreeAntineoplastic agent
dc.subject.emtreeImmunosuppressive agent
dc.subject.emtreeAcute myeloblastic leukemia
dc.subject.emtreeAllogeneic stem cell transplantation
dc.subject.emtreeCryptococcosis
dc.subject.emtreeDisease association
dc.subject.emtreeDrug monitoring
dc.subject.emtreeGraft versus host reaction
dc.subject.emtreeHematologic malignancy
dc.subject.emtreeHuman
dc.subject.emtreeInfection risk
dc.subject.emtreeInvasive aspergillosis
dc.subject.emtreeInvasive candidiasis
dc.subject.emtreeMass spectrometry
dc.subject.emtreeMeta analysis (topic)
dc.subject.emtreeMycosis
dc.subject.emtreeMyelodysplastic syndrome
dc.subject.emtreeRandomized controlled trial (topic)
dc.subject.emtreeReview
dc.subject.emtreeRisk assessment
dc.subject.emtreeTreatment outcome
dc.subject.emtreeAdverse effects
dc.subject.emtreeBlood
dc.subject.emtreeChemically induced
dc.subject.emtreeComplication
dc.subject.emtreeCross infection
dc.subject.emtreeDisinfection
dc.subject.emtreeFebrile neutropenia
dc.subject.emtreeHematologic neoplasms
dc.subject.emtreeImmunocompromised patient
dc.subject.emtreeInvasive fungal infections
dc.subject.emtreeOpportunistic infections
dc.subject.emtreePractice guideline
dc.subject.emtreeProcedures
dc.subject.emtreeSecondary prevention
dc.subject.emtreeTransplantation conditioning
dc.subject.meshAntifungal agents
dc.subject.meshAntineoplastic agents
dc.subject.meshCross infection
dc.subject.meshDisinfection
dc.subject.meshFebrile neutropenia
dc.subject.meshHematologic neoplasms
dc.subject.meshHumans
dc.subject.meshImmunocompromised host
dc.subject.meshImmunosuppressive agents
dc.subject.meshInvasive fungal infections
dc.subject.meshOpportunistic infections
dc.subject.meshPractice guidelines as topic
dc.subject.meshRisk assessment
dc.subject.meshSecondary prevention
dc.subject.meshTransplantation conditioning
dc.subject.scopusAntifungal agents; Posaconazole; Micafungin
dc.subject.wosHematology
dc.titleRecommendations for risk categorization and prophylaxis of invasive fungal diseases in hematological malignancies: A critical review of evidence and expert opinion (TEO-4)
dc.title.alternativeHematolojik malignitelerdeki invazif fungal enfeksiyon riskinin belirlenmesi ve profilaksi: Kanıtlara eleştirel bakış ve Türk uzman görüşleri (TUG-4)
dc.typeArticle
dc.wos.quartileQ4
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/İç Hastalıkları Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atScopus

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Özkalemkaş_vd_2015.pdf
Size:
247.72 KB
Format:
Adobe Portable Document Format
Description:
Download

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

İndeksli Yayınlar / Indexed Publications